Ozcan Birim

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi request reprint Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting
    O Birim
    Department of Cardio Thoracic Surgery, Erasmus MC Rotterdam, Rotterdam, The Netherlands
    J Cardiovasc Surg (Torino) 53:641-50. 2012
  2. ncbi request reprint Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode
    Ozcan Birim
    Department of Cardio Thoracic Surgery, Erasmus MC, Rotterdam, The Netherlands
    J Thorac Cardiovasc Surg 132:491-8. 2006
  3. doi request reprint Outcome after reoperation for atrioventricular septal defect repair
    Ozcan Birim
    Department of Cardio Thoracic Surgery, Erasmus MC Rotterdam, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands
    Interact Cardiovasc Thorac Surg 9:83-7. 2009
  4. doi request reprint Complexity of coronary vasculature predicts outcome of surgery for left main disease
    Ozcan Birim
    Department of Cardio Thoracic Surgery, Erasmus MC Rotterdam, The Netherlands
    Ann Thorac Surg 87:1097-104; discussion 1104-5. 2009
  5. ncbi request reprint Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer
    Ozcan Birim
    Department of Cardiothoracic Surgery, Erasmus MC Rotterdam, Rotterdam, The Netherlands
    Ann Thorac Surg 80:1021-6. 2005
  6. ncbi request reprint Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer
    Ozcan Birim
    Department of Cardio Thoracic Surgery, Erasmus MC Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Eur J Cardiothorac Surg 28:759-62. 2005
  7. doi request reprint Validation of a prognostic model to predict survival after non-small-cell lung cancer surgery
    Leonardus L R van der Pijl
    Erasmus MC Rotterdam, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands
    Eur J Cardiothorac Surg 38:615-9. 2010
  8. doi request reprint Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis
    Sahar Mokhles
    Department of Cardio Thoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands Electronic address
    Lung Cancer 87:283-9. 2015
  9. ncbi request reprint Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters
    Ozcan Birim
    Department of Cardiothoracic Surgery, Rotterdam, The Netherlands
    Ann Thorac Surg 79:1137-41. 2005
  10. doi request reprint Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis
    Sahar Mokhles
    Department of Cardio Thoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
    Ann Surg Oncol 22:316-23. 2015

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting
    O Birim
    Department of Cardio Thoracic Surgery, Erasmus MC Rotterdam, Rotterdam, The Netherlands
    J Cardiovasc Surg (Torino) 53:641-50. 2012
    ..The 5-year outcome of the ongoing SYNTAX trial is essential and might therefore provide new insights into the comparison of cost-effectiveness between CABG and DES PCI...
  2. ncbi request reprint Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode
    Ozcan Birim
    Department of Cardio Thoracic Surgery, Erasmus MC, Rotterdam, The Netherlands
    J Thorac Cardiovasc Surg 132:491-8. 2006
    ..We aimed to develop a prognostic model that can be used to estimate the postoperative survival of individual patients...
  3. doi request reprint Outcome after reoperation for atrioventricular septal defect repair
    Ozcan Birim
    Department of Cardio Thoracic Surgery, Erasmus MC Rotterdam, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands
    Interact Cardiovasc Thorac Surg 9:83-7. 2009
    ..Overall survival was 91%, and 86% after 5 and 15 years. The most common indication to undergo reoperation is LAVVR. Reoperation is safe and in the majority of cases, a durable repair of the LAVV can still be achieved...
  4. doi request reprint Complexity of coronary vasculature predicts outcome of surgery for left main disease
    Ozcan Birim
    Department of Cardio Thoracic Surgery, Erasmus MC Rotterdam, The Netherlands
    Ann Thorac Surg 87:1097-104; discussion 1104-5. 2009
    ....
  5. ncbi request reprint Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer
    Ozcan Birim
    Department of Cardiothoracic Surgery, Erasmus MC Rotterdam, Rotterdam, The Netherlands
    Ann Thorac Surg 80:1021-6. 2005
    ..In this report, treatment selection and the outcome of both surgically and nonsurgically treated patients is evaluated...
  6. ncbi request reprint Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer
    Ozcan Birim
    Department of Cardio Thoracic Surgery, Erasmus MC Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Eur J Cardiothorac Surg 28:759-62. 2005
    ..To evaluate the impact of the Charlson comorbidity index on long-term survival in nonsmall cell lung cancer surgery and determine whether this index is a better predictor of long-term survival than individual comorbid conditions...
  7. doi request reprint Validation of a prognostic model to predict survival after non-small-cell lung cancer surgery
    Leonardus L R van der Pijl
    Erasmus MC Rotterdam, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands
    Eur J Cardiothorac Surg 38:615-9. 2010
    ..Till present, this model has not been validated. The purpose of this study was to validate this model in patients operated on for primary NSCLC...
  8. doi request reprint Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis
    Sahar Mokhles
    Department of Cardio Thoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands Electronic address
    Lung Cancer 87:283-9. 2015
    ..As outcomes of prospective randomized clinical trials comparing these modalities are unavailable, we performed a propensity-score matched analysis to create two similar groups in order to compare clinical outcomes...
  9. ncbi request reprint Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters
    Ozcan Birim
    Department of Cardiothoracic Surgery, Rotterdam, The Netherlands
    Ann Thorac Surg 79:1137-41. 2005
    ..This study evaluates prognostic factors for survival in completely resected pathological stage IA nonsmall cell lung cancer with special emphasis on tumor size and assesses tumor recurrence rate by actual and actuarial analysis...
  10. doi request reprint Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis
    Sahar Mokhles
    Department of Cardio Thoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
    Ann Surg Oncol 22:316-23. 2015
    ..This study was designed to define clinical baseline parameters associated with impaired survival of patients with stage I or II non-small cell lung cancer (NSCLC) who underwent surgery or stereotactic body radiotherapy (SBRT)...
  11. ncbi request reprint Emergency surgery due to haematoma in a case of left atrial myxoma
    Ozcan Birim
    Department of Cardio Thoracic Surgery, Room BD 156, Erasmus MC Rotterdam, P O Box 2040, Dr Molewaterplein 40, 3015 GD, 3000 CA Rotterdam, The Netherlands
    Heart Lung Circ 15:191-3. 2006
    ..This case illustrates that the clinical condition of patients with symptomatic myxoma can deteriorate suddenly and require urgent surgical treatment...
  12. ncbi request reprint Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer
    Ozcan Birim
    Department of Cardiothoracic Surgery, Rotterdam, The Netherlands
    Ann Thorac Surg 79:375-82. 2005
    ..65 to 0.75). The difference was highly significant (p < 0.0001). We conclude that 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography is more accurate than computed tomography in detecting mediastinal lymph node metastases...
  13. ncbi request reprint Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population
    Ozcan Birim
    Department of Cardiothoracic Surgery, Erasmus Medical Center Rotterdam, Rotterdam, Netherlands
    Ann Thorac Surg 76:1796-801. 2003
    ..However, risk factors for hospital mortality and the benefits for the patients in the long term are insufficiently defined, and survival compared with the general population is not known...